Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06849830 · ClinicalTrials.gov registry record · NA
Incorporating Narrative Into the Treatment of Youth With Anorexia Nervosa
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT06849830 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 8 participants.
The verdict
NCT06849830, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to evaluate whether a narrative medicine (NM) curriculum can enhance self-expression, reflection, and resilience in adolescents and young adults with anorexia nervosa. The main questions it aims to answer are: * Does participation in an NM curriculum improve self-expression and reflection in individuals with anorexia nervosa? * Does engaging in creative writing and group discussion promote resilience and emotional processing in this population? Participants will be 16-25 years old, medically stable for outpatient eating disorder therapy, and actively engaged in treatment. Those with active suicidal ideation, recent non-suicidal self-injury, or a co-occurring personality disorder will not be eligible. Participants will: * Attend six weekly workshops (April-May 2025) focused on themes such as self-definition, kindness, resilience, and possibility * Engage in close reading of visual or written texts * Complete creative writing exercises in response to prompts * Participate in group discussions and sharing An optional capstone reading event will provide a supportive space for participants to share their work with peers, loved ones, and providers, fostering connection and community. This study aims to explore the role of narrative medicine in eating disorder treatment and assess its potential benefits for psychological well-being and self-expression.
Interventions
- BEHAVIORAL Narrative Medicine (NM) Workshop Series
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2025-03-19 |
| Est. Completion | 2025-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06849830
The ClinicalTrials.gov registry entry for NCT06849830 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Narrative Medicine (NM) Workshop Series is the first listed.
NCT06849830 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06849830 about?
NCT06849830 is a clinical study titled "Incorporating Narrative Into the Treatment of Youth With Anorexia Nervosa". The goal of this clinical trial is to evaluate whether a narrative medicine (NM) curriculum can enhance self-expression, reflection, and resilience in adolescents and young adults with anorexia nervosa. The main questions it aims to answer are: * Does participation in an NM curriculum improve self...
What is the current status of trial NCT06849830?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2025-03-19. Estimated completion is 2025-05-31.
What interventions are being tested in trial NCT06849830?
The interventions under investigation include: Narrative Medicine (NM) Workshop Series (BEHAVIORAL).
Who is sponsoring clinical trial NCT06849830?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.